Molecular predictors of response to azacitidine therapy: the results of the UK trials acceleration programme RAVVA study

Craddock, C; Quek, L; Houlton, A; Ferguson, P; Gbandi, E; Roberts, C; Metzner, M; Wheatley, K; Siddique, S; Pillai, S; Dennis, M; Cavenagh, J; Vyas, P

Conference item

Molecular predictors of response to azacitidine therapy: the results of the UK trials acceleration programme RAVVA study

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Craddock, C., Quek, L., Houlton, A., Ferguson, P., Gbandi, E., Roberts, C., Metzner, M., Wheatley, K., Siddique, S., Pillai, S., Dennis, M., Cavenagh, J., & Vyas, P. (2017). Molecular predictors of response to azacitidine therapy: the results of the UK trials acceleration programme RAVVA study. Haematologica, 102(S2), 323.

MLA Style

Craddock, C., et al. “Molecular Predictors of Response to Azacitidine Therapy: the Results of the UK Trials Acceleration Programme RAVVA Study.” Haematologica, vol. 102, no. S2, Ferrata Storti Foundation, 2017, p. 323.

Chicago Style

Craddock, C, L Quek, A Houlton, P Ferguson, E Gbandi, C Roberts, M Metzner, et al. 2017. “Molecular Predictors of Response to Azacitidine Therapy: the Results of the UK Trials Acceleration Programme RAVVA Study.” In Haematologica, 102:323. 22nd Congress of the European Hematology Association Madrid, Spain June 22-25, 2017. Ferrata Storti Foundation.
Share
Print

Access Document

Files:: Craddock_etal_2017_Molecular_predictors_of_response.pdf

(Preview, Version of record, pdf, 48.9KB, Terms of use)

Authors

+ Craddock, C More by this author

Role:: Author

+ Quek, L More by this author

Institution:: University of Oxford
Division:: Medical Sciences Division
Department:: RDM
Sub department:: RDM Clinical Laboratory Sciences
Role:: Author

+ Houlton, A More by this author

Role:: Author

+ Ferguson, P More by this author

Role:: Author

+ Gbandi, E More by this author

Role:: Author

More authors...

Publisher:: Ferrata Storti Foundation
Host title:: Haematologica
Journal:: Haematologica More from this journal
Volume:: 102
Issue:: S2
Pages:: 323
Series:: 22nd Congress of the European Hematology Association Madrid, Spain June 22-25, 2017
Publication date:: 2017-06-26
EISSN:: 1592-8721
ISSN:: 0390-6078

Pubs id:: pubs:718568
UUID:: uuid:4f428ea9-479e-4fd0-b482-f00e23b3a139
Local pid:: pubs:718568
Source identifiers:: 718568
Deposit date:: 2018-11-08

Terms of use

Copyright holder:: Ferrata-Storti Foundation/European Hematology Association
Notes:: ©2017 by the Ferrata-Storti Foundation/European Hematology Association. This is the Ferrata Storti Foundation version of the article. The final version is available online from Ferrata Storti Foundation at: http://www.haematologica.org/content/102/s2/1

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

Conference item

Molecular predictors of response to azacitidine therapy: the results of the UK trials acceleration programme RAVVA study

Actions

Access Document

Authors

Terms of use

Views and Downloads

Altmetrics

Dimensions

Conference item

Molecular predictors of response to azacitidine therapy: the results of the UK trials acceleration programme RAVVA study

Actions

Access Document

Authors

Bibliographic Details

Item Description

Terms of use

Metrics

Views and Downloads

Altmetrics

Dimensions